Pharmaron shareholders approve key resolutions, new independent director

Pharmaron Beijing Co., Ltd. announced the successful passing of all resolutions at its First Extraordinary General Meeting of 2025 (EGM) held on December 18, 2025. A total of 860,821,389 shares, representing approximately 48.6084% of the total voting rights, were cast by shareholders. Ordinary resolutions, including the by-election of an independent non-executive director and amendments to various management policies, passed with over 99.94% of votes in favor.

Specifically, the by-election of an independent non-executive director secured 860,312,319 votes (99.9409%) in favor, with only 359,845 votes (0.0418%) against and 149,225 (0.0173%) abstentions. Amendments to the articles of association, a special resolution, also passed with strong support, receiving 860,372,320 votes (99.9478%) in favor.

Following the EGM, Prof. Tsang King Fung has been appointed as an independent non-executive director with immediate effect, succeeding Mr. Tsang Kwan Hung Benson, who resigned from his role and committee memberships. The company also confirmed that shareholders authorized an increase in registered capital and amendments to the articles of association.